Safety Information

Safety Information

 


Medical Product
Reporting

Reporting Adverse Events to the FDA

Welcome to MedWatch, your Internet gateway for timely safety information on the drugs and other medical products regulated by the U.S. Food and Drug Administration.

A Message About HIPAA Compliance for Reporters to FDA MedWatch New

FDA Logo links to FDA home page
U.S. Food and Drug Administration
  HHS Logo links to Department of Health and Human Services website
 MedWatch logoThe FDA Safety Information and Adverse Event Reporting Program


Join the E-list
Get safety alerts by e-mail

What's New

Public Health Advisory: Suicidality in Children and Adolescents Being Treated with Antidepressant Medications - Manufacturers of all antidepressant drugs asked to include in their labeling a boxed warning and expanded warning statements that alert health care providers to an increased risk of suicidality.
(Posted 10/15/2004)

Remicade (infliximab) - In controlled studies of all TNFα-blocking agents, including Remicade, more cases of lymphoma have been observed among patients receiving the agents than among control group patients.
(Posted 10/13/2004)

Rituxan (rituximab) - Reports of Hepatitis B reactivation with fulminant hepatitis, hepatic failure, and death in some patients.
(Posted 10/08/2004)

Levoxyl (levothyroxine sodium) - Reports of tablets stuck in throat, with choking, gagging and dysphagia, occurring predominately when not taken with water.
(Posted 10/04/2004)

Pulmonetic Systems LTV Series of Ventilators - Class I recall due to a malfunction when switching to the internal battery, causing failure of the ventilator to breathe for the patient.
(Posted 9/30/2004)

Zometa (zoledronic acid) Injection - Reports of osteonecrosis of the jaw mainly in cancer patients, who have received bisphosphonates as a component of their therapy.
(Posted 9/30/2004)

Vioxx (rofecoxib) - Voluntary market withdrawal due to an increased risk for serious cardiovascular events, such as heart attacks and strokes, first observed after 18 months of continuous treatment with Vioxx compared with placebo.
(Posted 9/30/2004)

 
horizonal rule